Literature DB >> 11334971

Strategies to generate antibodies capable of distinguishing between proteins with >90% amino acid identity.

H M Sleister1, A G Rao.   

Abstract

Protein engineering is a common strategy for the generation of protein variants with new properties. The engineered variants often have a high degree of similarity with the wild-type progenitor protein, necessitating a tool (e.g., antibody) to distinguish the wild-type and variant protein forms. As part of an overall effort to understand the process of incorporation of amino acids into storage proteins during seed fill in soybean, we have engineered a variant of soybean vegetative storage protein beta (VSPbeta) that is 91.8% identical in amino acid sequence to the wild-type protein, but contains 10% methionine (VSPbeta-Met, unpublished results). Thus, it would be desirable to have antibodies that specifically recognize VSPbeta-Met over the endogenously expressed wild-type protein in transgenic plants. To this end, we compared three strategies for the isolation of VSPbeta-Met-specific antibodies: (1) hybridoma production using VSPbeta-Met protein as the antigen, (2) polyclonal antibody production in rabbits using a peptide antigen corresponding to a methionine-rich region of VSPbeta-Met, and (3) subtractive immunization in mice using VSPbeta-WT as the tolerogen, cyclophosphamide for immunosuppression and VSPbeta-Met as the immunogen. While the first strategy generated antibodies cross-reactive to both antigens, the second strategy generated polyclonal antibodies that preferentially recognized the variant protein in immunoblots. However, using subtractive immunization, we were able to generate mouse polyclonal antibodies that exhibited 10-fold greater reactivity with VSPbeta-Met than VSPbeta-WT in an ELISA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334971     DOI: 10.1016/s0022-1759(01)00346-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Increased abundance of opioid receptor heteromers after chronic morphine administration.

Authors:  Achla Gupta; Jan Mulder; Ivone Gomes; Raphael Rozenfeld; Ittai Bushlin; Edmund Ong; Maribel Lim; Emeline Maillet; Mats Junek; Catherine M Cahill; Tibor Harkany; Lakshmi A Devi
Journal:  Sci Signal       Date:  2010-07-20       Impact factor: 8.192

2.  AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.

Authors:  Raphael Rozenfeld; Achla Gupta; Khatuna Gagnidze; Maribel P Lim; Ivone Gomes; Dinah Lee-Ramos; Natalia Nieto; Lakshmi A Devi
Journal:  EMBO J       Date:  2011-05-03       Impact factor: 11.598

3.  G-protein-coupled heteromers: regulation in disease.

Authors:  Ivone Gomes; Achla Gupta; Lakshmi A Devi
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

4.  Generation of monoclonal antibodies specific for cell surface molecules expressed on early mouse endoderm.

Authors:  Paul Gadue; Valerie Gouon-Evans; Xin Cheng; Ewa Wandzioch; Kenneth S Zaret; Markus Grompe; Philip R Streeter; Gordon M Keller
Journal:  Stem Cells       Date:  2009-09       Impact factor: 6.277

5.  Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress.

Authors:  M C Gold; T Eid; S Smyk-Pearson; Y Eberling; G M Swarbrick; S M Langley; P R Streeter; D A Lewinsohn; D M Lewinsohn
Journal:  Mucosal Immunol       Date:  2012-06-13       Impact factor: 7.313

6.  Protocadherin 11X/Y a human-specific gene pair: an immunohistochemical survey of fetal and adult brains.

Authors:  Thomas H Priddle; Tim J Crow
Journal:  Cereb Cortex       Date:  2012-06-28       Impact factor: 5.357

7.  A rapid subtractive immunization method to prepare discriminatory monoclonal antibodies for food E. coli O157:H7 contamination.

Authors:  Min Jin; Jing Lang; Zhi-Qiang Shen; Zhao-Li Chen; Zhi-Gang Qiu; Xin-Wei Wang; Jun-Wen Li
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

Review 8.  Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function.

Authors:  Ivone Gomes; Achla Gupta; Ittai Bushlin; Lakshmi A Devi
Journal:  Front Pharmacol       Date:  2014-12-03       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.